Now May Be the Time for Pharma to Get Serious About Instagram
Despite the fact that FDA recently cited Duchesnay for a violative Instagram Diclegis ad that featured celebrity Kim Kardashian (read"Kim Kardashian Instagram post draws FDA warning"), Instagram may be the social medium of choice of pharma marketers now that it has added a new feature.Until now, I didn't think Instagram was good for pharma. While its demographics (see charts below) may skew too young for marketing most of the products pharma has to sell, it is a growing population. Plus, now that Instagram is owned by Facebook, the demographics -- especially among women (the best target for drug marketing) --...
Source: Pharma Marketing Blog - August 15, 2016 Category: Pharmaceuticals Tags: Instagram patient stories social media marketing Source Type: blogs
Differentiating Strategies in Healthcare to Separate Yourself from the Competition
The New Health Economy has arrived, bringing with it a crushing set of challenges for the biopharma industry. Pharmaceutical companies must rapidly – and strategically – adapt to stay competitive while dealing with mounting cost pressures, greater demand for services, and increased digitization. The key to navigating this unsettled landscape is a capabilities-driven strategy. Companies that adopt this approach have a clear way to play, the underlying capabilities needed to execute, and an aligned portfolio and geographic focus. “Positioning for success in biopharma requires a self-critical analysis of the risk a...
Source: ePharma Summit - August 12, 2016 Category: Pharmaceuticals Tags: #digitalhealth biopharma Biotech health economy Health Strategy Source Type: blogs
Do Desperate Consumers Believe Cancer Drug DTC Ads?
In a recent NYT OpEd piece, Matt Jablow, whose wife died of lung cancer, called the TV ads for BMS's cancer drug Opdivo"utterly misleading and exploitive" and said that if BMS really wishes to thank patients like his wife who participated in the Opdivo drug trials, it should pull the ads (read the OpEd piecehere).The Opdivo ad had already been criticized during an investor conference call by a Deutsche Bank analyst who questioned the value of direct-to-consumer (DTC) ads to promote Opdivo (here). Of course, the analyst was more concerned about BMS wasting money on ads that would have no effect on the sales of...
Source: Pharma Marketing Blog - August 12, 2016 Category: Pharmaceuticals Tags: Bob Ehrlich cancer DTC Advertising Opdivo Source Type: blogs
Total CME Funding Drops, But Income from Pharma Increases
The AMA& many other physician groups are lobbying in support of a Senate bill to exempt drug and device makers from reporting the value of continuing medical education (CME), journal reprints, and textbooks provided to physicians (seehere).At the same time, while total accredited CME income is decreasing, the pharma industry is upping its financial support of CME, according to the2015 Annual Report of the Accreditation Council for Continuing Medical Education (ACCME).Data from ACCME Annual Reports. Click on image for an enlarged, more readable view.However, pharma may be channeling money to CME through organizations th...
Source: Pharma Marketing Blog - August 10, 2016 Category: Pharmaceuticals Tags: ACCME payments to physicians Sunshine law Source Type: blogs
Igniting Biotech Innovation in Neurodegenerative Disorders
It is widely recognized that neurodegenerative disorders represent one of the most challenging areas for new drug development. These diseases have devastating human cost on the lives of patients and families, as well as a burden on healthcare systems and society. For example, the cost to society of Alzheimer ’s disease is estimated to skyrocket to $1 trillion annually in the U.S. by the year 2050.In spite of the challenges, research and drug development in neuroscience and neurodegenerative diseases is pushing new frontiers. The prospect of real breakthroughs is on the horizon. If we imagine the possi...
Source: ePharma Summit - August 8, 2016 Category: Pharmaceuticals Tags: #PSANYC16 alzheimers disease alzheimers drug development biotech companies biotech innovation neurodegenerative disorders Pharmaceutical Strategy Conference Source Type: blogs
FDA's Dependence on User Fees & " Institutional Corruption " Blamed for Dramatic Increase in Drug Adverse Events and Deaths
Did you know that prescription drugs are the 4th leading cause of death in the U.S.? This does not include deaths and hospitalizations from over-dosing, errors, or recreational drug use. We know this because of hundreds of thousands of drug & quot;Adverse Event Reports & quot; (AERs) every year & quot;Adverse Event Reports & quot; received by the FDA directly from healthcare professionals (HCPs such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, lawyers and others), and drug companies, which are normally required to send AERs it receives from HCPs to the FDA. < br > < br > Th...
Source: Pharma Marketing Blog - July 25, 2016 Category: Pharmaceuticals Tags: Adverse events AER Drug Safety PDUFA Source Type: blogs
Novartis Respects the Patient Perspective and Pays for It Too! But Is It Absolutely Transparent?
On Patientpower.eu, David Palacios, Head of Global Patient Relations, and Sanja Njegic, Head of Patient Advocacy & amp; Relations in Europe at Novartis, explain how their company has moved from working with doctors and payers to working directly with patients. The interview was recorded at Eyeforpharma Barcelona 2016. < br > < br > < iframe allowfullscreen= " " frameborder= " 0 " height= " 300 " mozallowfullscreen= " " src= " https://player.vimeo.com/video/169505006 " webkitallowfullscreen= " " width= " 500 " > < /iframe > < br > < br > “We developed last year what we call the & #39;patient declaration, & #39; whic...
Source: Pharma Marketing Blog - July 23, 2016 Category: Pharmaceuticals Tags: Janssen Novartis Patient Advocacy patient opinion leader patient-centricity payments to physicians transparency Source Type: blogs
Fifty Ways to Leave the GOP
This morning I saw this tweet by a journalist: < br > < br > < div class= " separator " style= " clear: both; text-align: center; " > < a href= " https://4.bp.blogspot.com/-SYbkAvzrB4Q/V5EPzo0viNI/AAAAAAAAIxo/k68NWrzWI5sdFXfyWdUN_uANp4izcXNmgCLcB/s1600/How-to-Quit-GOP.jpg " imageanchor= " 1 " style= " margin-left: 1em; margin-right: 1em; " > < img border= " 0 " height= " 325 " src= " https://4.bp.blogspot.com/-SYbkAvzrB4Q/V5EPzo0viNI/AAAAAAAAIxo/k68NWrzWI5sdFXfyWdUN_uANp4izcXNmgCLcB/s400/How-to-Quit-GOP.jpg " width= " 400 " > < /a > < /div > Talk about & quot;Open Carry & quot; in Ohio - This is & quot;Open Nazism! &...
Source: Pharma Marketing Blog - July 21, 2016 Category: Pharmaceuticals Source Type: blogs
3 Types of Services Physicians Can Use to Build their Practice
< blockquote class="tr_bq" > < span style="font-family: inherit;" > < br / > < /span > < /blockquote > < div class="separator" style="clear: both; text-align: center;" > < a href="https://1.bp.blogspot.com/-r6hg4-FwPUw/V5DxpiXEPHI/AAAAAAAAABE/p1pSTPYqj14ll4EuB7XL3Xgfep79yUCuwCLcB/s1600/3-Ways-Physicians-Build-Practice.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;" > < img border="0" height="213" src="https://1.bp.blogspot.com/-r6hg4-FwPUw/V5DxpiXEPHI/AAAAAAAAABE/p1pSTPYqj14ll4EuB7XL3Xgfep79yUCuwCLcB/s320/3-Ways-Physicians-Build-Practice.jpg" width="320" / > < /a > < /div > < br / > < span style="font-siz...
Source: ePharma Summit - July 21, 2016 Category: Pharmaceuticals Tags: HCPs health marketing IT Medical Billing Medical practices Pharma Physicians technology Source Type: blogs
Real Dog Patient Stories Send Sales of Sileo Rocketing!
"Data gives credibility, but stories provide truth," says Ash Rishi, Co-Founder and Managing Director of COUCH (read "Patient Storytelling Marketing").Social media and patient stories are a "match made in heaven" and several pharma marketers are using social media to listen to REAL patient stories and to leverage those stories to help motivate other patients. This is as true for dogs as it is for humans as evidenced by Chase's story (see him on the left).Before I get to that, some background.It is estimated that one-third of dogs in the U.S. suffer from noise aversion and they especially h...
Source: Pharma Marketing Blog - July 20, 2016 Category: Pharmaceuticals Tags: Dogs patient testimonial Sileo Source Type: blogs
Apple's ResearchKit Mobile Apps Make Strides in Clinical Research, But Is iPhone User Demographics an Issue?
As reported in the trade media, GSK developed an iPhone app for use in "clinical research" (read "GSK Develops Rheumatoid Arthritis App for Clinical Trial Using Apple's ResearchKit"). It is claimed that this "[marks] the first time a drugmaker has used the health system for the iPhone to conduct clinical research." ResearchKit is a set of tools for collecting participant consent, conducting surveys and assigning active tasks to participants that they can perform to help researchers achieve specific study goals.Keep in mind, however, that this use of a ResearchKit iPhone app is not part of ...
Source: Pharma Marketing Blog - July 20, 2016 Category: Pharmaceuticals Tags: Clinical Trials GSK iPhone ResearchKit Source Type: blogs
Apple's ResearchKit Mobile Apps Make Strides in Clinical Research, But Is iPhone User Demographics an Issue?
< div class= " separator " style= " clear: both; text-align: center; " > < /div > < div class= " separator " style= " clear: both; text-align: center; " > < a href= " https://2.bp.blogspot.com/-G080faOPPfE/V49eHZUb6KI/AAAAAAAAIw4/cy9mTJIVFwwlgM0slc1Orc3MA0c7Xme8wCLcB/s1600/PARADEstudy-iPhoneScreen.jpg " imageanchor= " 1 " style= " clear: left; float: left; margin-bottom: 1em; margin-right: 1em; " > < img border= " 0 " height= " 320 " src= " https://2.bp.blogspot.com/-G080faOPPfE/V49eHZUb6KI/AAAAAAAAIw4/cy9mTJIVFwwlgM0slc1Orc3MA0c7Xme8wCLcB/s320/PARADEstudy-iPhoneScreen.jpg " width= " 204 " > < /a > < /div > As repor...
Source: Pharma Marketing Blog - July 20, 2016 Category: Pharmaceuticals Tags: Clinical Trials GSK iPhone ResearchKit Source Type: blogs
Poof! FaceBook & SnapChat Offer Pharma Marketers Transient, Untraceable Messaging
Poof! FB & SnapChat Offer #pharma Marketers Transient, Untraceable Messaging (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - July 14, 2016 Category: Pharmaceuticals Tags: FaceBook SnapChat Source Type: blogs
Poof! FaceBook & SnapChat Offer Pharma Marketers Transient, Untraceable Messaging
< div id= ' scoopit-container-4066376971 ' > < a href= ' http://www.scoop.it/t/pharmaguy-s-social-media-news-views/p/4066376971/2016/07/14/poof-fb-snapchat-offer-pharma-marketers-transient-untraceable-messaging ' > Poof! FB & SnapChat Offer #pharma Marketers Transient, Untraceable Messaging < /a > < /div > < script type= ' text/javascript ' src= ' http://www.scoop.it/embed-scoop/4066376971.js?maxwidth=457 ' > < /script > (Source: Pharma Marketing Blog)
Source: Pharma Marketing Blog - July 14, 2016 Category: Pharmaceuticals Tags: FaceBook SnapChat Source Type: blogs
Healthcare Marketing: Adapting in the Digital Age
As more consumers seek out healthcare providers independently of that of their employers, there is a noticeable, and growing, shift in the market space. Healthcare providers are forced to find ways to market to consumers directly.In September 2015, Forbes published an article, The New World of Healthcare Marketing: A Framework For Adaptation, detailing much of that shift and what marketers can do to bridge the gap between Health Care Providers (HCPs) and consumers."As consumers take a more active role in their healthcare decisions, marketers must listen and adapt in order to remain relevant. To frame this shift and identif...
Source: ePharma Summit - July 13, 2016 Category: Pharmaceuticals Tags: Big Pharma Digital Health ePharma Healthcare Healthcare marketing Source Type: blogs
